Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

07. Mai 2015 08:00 ET | Quelle: Neothetics, Inc.

Neothetics to Release First Quarter 2015 Financial Results, Host Annual Stockholder Meeting

SAN DIEGO, May 7, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that it...
13. April 2015 08:00 ET | Quelle: Neothetics, Inc.

Neothetics Initiates Pivotal Phase 3 Clinical Trials for LIPO-202, the First Non-Invasive Injectable Drug Candidate for Reduction of Subcutaneous Abdominal Fat

SAN DIEGO, April 13, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
08. April 2015 08:00 ET | Quelle: Neothetics, Inc.

Neothetics to Present at Needham & Company's 14th Annual Healthcare Conference

SAN DIEGO, April 8, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
26. März 2015 08:00 ET | Quelle: Neothetics, Inc.

Neothetics Reports Fourth Quarter and Full Year 2014 Financial Results

SAN DIEGO, March 26, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today reported...
23. März 2015 09:30 ET | Quelle: Neothetics, Inc.

Neothetics Initiates Study to Evaluate Safety of Retreatment With LIPO-202 for Body Contouring

SAN DIEGO, March 23, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced it has...
04. März 2015 08:00 ET | Quelle: Neothetics, Inc.

Neothetics to Present at the 27th Annual Roth Conference

SAN DIEGO, March 4, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
25. Februar 2015 08:00 ET | Quelle: Neothetics, Inc.

Neothetics to Present at Cowen and Company 35th Annual Health Care Conference

SAN DIEGO, Feb. 25, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced that...
12. Februar 2015 08:00 ET | Quelle: Neothetics, Inc.

Leading Aesthetic Physicians Join Neothetics' Newly Formed Corporate Advisory Board

SAN DIEGO, Feb. 12, 2015 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
01. Dezember 2014 08:00 ET | Quelle: Neothetics, Inc.

Neothetics Announces Closing of Upsized Initial Public Offering

SAN DIEGO, Dec. 1, 2014 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...
19. November 2014 19:35 ET | Quelle: Neothetics, Inc.

Neothetics Prices Initial Public Offering

SAN DIEGO, Nov. 19, 2014 (GLOBE NEWSWIRE) -- Neothetics, Inc. (Nasdaq:NEOT), a clinical-stage specialty pharmaceutical company developing therapeutics for the aesthetic market, today announced the...

Vorherige Seite